43 results on '"D. Perdu"'
Search Results
2. Liposarcome myxoïde primitif du médiastin
- Author
-
S. Rubin, Gaëtan Deslée, O. Toubas, P. Magdeleinat, D. Perdu, V. Cahn, P. Validire, J.-M. Perotin, and François Lebargy
- Subjects
Pulmonary and Respiratory Medicine ,Chemotherapy ,medicine.medical_specialty ,business.industry ,medicine.medical_treatment ,Soft tissue sarcoma ,Respiratory disease ,Mediastinum ,Liposarcoma ,medicine.disease ,Surgery ,Radiation therapy ,medicine.anatomical_structure ,medicine ,Thoracotomy ,Radiology ,business ,Neoadjuvant therapy - Abstract
Mediastinal liposarcomas (LPS) are rare tumours. We report a case of primary myxoid LPS in a 22-year-old woman suffering from cough, dyspnoea on exercise and asthenia for 3 weeks. Thoracic MRI showed a large tumour on the right side. After neoadjuvant chemotherapy, a complete resection was performed, followed by adjuvant thoracic irradiation. Eighteen months after the diagnosis, no sign of recurrence was detected. Mediastinal LPS include a heterogeneous group of bulky tumours, the progression of which depends on the histological type. The prognosis is dominated by the operability of the tumour. Adjuvant therapies are not established.
- Published
- 2011
- Full Text
- View/download PDF
3. Induction or consolidation chemotherapy for unresectable stage III non-small-cell lung cancer patients treated with concurrent chemoradiation: a randomised phase II trial GFPC - IFCT 02-01
- Author
-
L. Gérinière, Jean-Pierre Daurès, G. Robinet, E. Jonveaux, S. Bota, R. Gervais, Hervé Le Caer, J. Mandet, L. Falchero, L. Thiberville, J. Créquit, S. Ramdane, R. Poirier, D. Coetmeur, B. Lamezec, G.M. Jung, S. Schouabe, O. Gallocher, P. Clavére, P. Fournel, E. Touboul, A. Vergnenégre, A. D'Hombres, B. Kin, F. Mornex, Christos Chouaid, Pierre-Jean Souquet, F. Blanchon, Marie-Cécile Bozonnat, J.N. Talabard, A. Rivière, Isabelle Martel-Lafay, B. Mennecier, M. Perol, P.J. Souquet, A. Lavolé, S. Bayle, F. Barlesi, T. Pignon, Pierre Fournel, H. Le Caer, J.P. Labat, A. Vergnenegre, E. Tessier, C. Gimenez, H. Léna, P. Thomas, P. Barre, G. Zalcman, D. Perdu, Y. Coscas, J.C. Pietra, P. Martin, D. Lerouge, D. Herman, J.Y. Delhoume, J. M. Chavaillon, B. Melloni, J.M. Chavaillon, R. Trouette, M. Benchalal, D. Arpin, C. Decroisette, B. Milleron, I. Martel-Lafay, A. Cauchois, H. Ramos, A. Roquette, J. Letreut, H. Berard, D. Paillotin, A. Ducolone, J.M. Vernejoux, P. Verrelle, J.C. Bout, J.P. Suchaud, H. Janicot, Radj Gervais, A. Zribi, A. Benyoub, V. Grangeon, Gilles Robinet, C. Bonnamour, M. Grivaux, C. Chouaid, E. Quoix, C. Belleguic, P. Merle, E. Dansin, M.A. Zawadi, Hervé Lena, and J.B. Auliac
- Subjects
0301 basic medicine ,Oncology ,Adult ,Male ,Cancer Research ,medicine.medical_specialty ,Lung Neoplasms ,Time Factors ,Paclitaxel ,medicine.medical_treatment ,Phases of clinical research ,Vinorelbine ,Vinblastine ,Disease-Free Survival ,03 medical and health sciences ,0302 clinical medicine ,Risk Factors ,Internal medicine ,Carcinoma, Non-Small-Cell Lung ,Antineoplastic Combined Chemotherapy Protocols ,medicine ,Humans ,Lung cancer ,Aged ,Neoplasm Staging ,Cisplatin ,Chemotherapy ,business.industry ,Induction chemotherapy ,Consolidation Chemotherapy ,Radiotherapy Dosage ,Chemoradiotherapy ,Induction Chemotherapy ,Middle Aged ,medicine.disease ,Survival Analysis ,030104 developmental biology ,Treatment Outcome ,030220 oncology & carcinogenesis ,Female ,business ,medicine.drug - Abstract
Purpose The objective of this randomised phase II study was to evaluate the impact in terms of response and toxicities of induction or consolidation chemotherapy respectively before or after concurrent chemoradiotherapy in unresectable stage III non-small-cell lung cancer. Patients and methods In the induction arm, patients received induction chemotherapy with cisplatin (80 mg/m 2 ) and paclitaxel (200 mg/m 2 ) on days 1 and 29 followed by a concurrent chemoradiotherapy (66 Gy in 33 fractions, cisplatin 80 mg/m 2 days 1, 29 and 57, vinorelbine 15 mg/m 2 days 1, 8, 29, 36, 57 and 64). In consolidation arm, the same concurrent chemoradiotherapy began on day 1 followed by two cycles of cisplatin and paclitaxel. Results One hundred twenty seven patients were randomised. The intent to treat response rates in induction and consolidation arms were 58% and 56% respectively. Median survival was 19.6 months in induction arm and 16.3 months in consolidation arm and 4-year survival rates were 21% and 30% respectively. Haematologic and non-haematologic toxicities were similar in both arms, except grade 3/4 oesophagitis, more frequent in consolidation arm than in induction arm (17% versus 10%). Conclusion Cisplatin-based chemotherapy as induction or consolidation with concurrent chemoradiotherapy can be administrated safely. Response rates were similar in both arms with a trend in favour for consolidation arm for long-term survival.
- Published
- 2015
4. Pneumopathie des cracheurs de feu
- Author
-
François Lebargy, Gaëtan Deslée, S. Hirshi, Sandra Dury, B. Mouchet, F. Menivale, M.-C. Quinquenelle, P. Betbeze, and D. Perdu
- Subjects
Gynecology ,medicine.medical_specialty ,Lung disease ,business.industry ,Medicine ,General Medicine ,business - Abstract
Resume Introduction Lors de leurs demonstrations, les cracheurs de feu utilisent le plus souvent le kerdane, produit derive du petrole. L’inhalation accidentelle du kerdane est a l’origine de manifestations respiratoires decrites sous le nom de pneumopathie des “cracheurs de feu”. Observations Nous rapportons 8 cas de pneumopathie des cracheurs de feu. Les caracteristiques cliniques, radiologiques et evolutives, ont ete comparees aux 44 cas decrits dans la litterature francophone et anglo-saxonne. La presentation etait stereotypee : survenue chez un adulte jeune et inexperimente; une phase initiale immediate, caracterisee par une toux et des troubles digestifs; apres une phase de latence, apparition d’une symptomatologie respiratoire pseudo-infectieuse s’associant frequemment a des manifestations extra-respiratoires le plus souvent digestives; une evolution clinique et radiologique habituellement favorable, rarement compliquee par la formation de pneumatoceles ou la survenue d’un pneumothorax. Conclusion Le diagnostic des pneumopathies des cracheurs de feu repose sur l’anamnese et sur un ensemble clinique et radiologique tres caracteristique. Le traitement est symptomatique. La prevention repose sur une diffusion de l’information concernant les risques lies a l’exercice de cracheur de feu.
- Published
- 2005
- Full Text
- View/download PDF
5. [Systemic lupus erythematosus presenting as severe alveolar hypoventilation and the shrinking lung syndrome]
- Author
-
Y, Ammar, C, Launois, J-M, Perotin, S, Dury, A, Servettaz, D, Perdu, H, Vallerand, J, Nardi, C, Boulagnon-Rombi, M, Pluot, F, Lebargy, and G, Deslee
- Subjects
Diagnosis, Differential ,Lung Diseases ,Male ,Humans ,Lupus Erythematosus, Systemic ,Radiography, Thoracic ,Hypoventilation ,Syndrome ,Severity of Illness Index ,Aged - Abstract
The shrinking lung syndrome (SLS) is a rare complication of systemic lupus erythematosus.A 69-year-old man presented with exertional dyspnoea, muscle weakness, and weight loss of 15kg in 6months. Pulmonary function tests revealed a restrictive lung disorder, with a dramatic decrease in maximal inspiratory pressure (17% of theoretical value), and alveolar hypoventilation (pH 7.43; PaCOThe interesting features of this case report consist of: 1) the presentation of the SLS as an alveolar hypoventilation with a fatal outcome, 2) the presentation of systemic lupus as SLS.
- Published
- 2015
6. Allergie à Candida albicans: un cas de balanite traitée par désensibilisation spécifique
- Author
-
J.F. Fontaine, Ph. Betbeze, F. Lavaud, D. Perdu, and François Lebargy
- Subjects
Gynecology ,medicine.medical_specialty ,Anesthesiology and Pain Medicine ,biology ,business.industry ,medicine.medical_treatment ,Penile Diseases ,Immunology and Allergy ,Medicine ,business ,Candida albicans ,biology.organism_classification ,Desensitization (medicine) - Abstract
Resume Les auteurs rapportent l'observation d'un patient âge de 49 ans qui presente depuis trois ans des episodes de balanite a repetition dont le bilan etiologique est jusqu'alors reste negatif. Le prick-test et l'intradermoreaction a Candida albicans sont tous deux tres positifs, et le RAST met en evidence des IgE seriques specifiques pour cette levure. L'anamnese, les resultats des tests cutanes, la survenue de reactions syndromiques apres la realisation de l'intradermoreaction a Candida albicans ou de certaines injections d'extrait allergenique, et l'evolution favorable du tableau clinique avec le suivi d'une desensibilisation specifique, permettent d'evoquer le diagnostic de balanite recidivante en rapport avec une allergie IgE-dependante a Candida albicans. Cette observation presente le double interet d'attirer l'attention quant a l'existence eventuelle d'une allergie immediate IgE-dependante a Candida albicans, dont le role est evoque par certains auteurs dans la survenue de vulvo-vaginites recidivantes, et de discuter un nouveau diagnostic etiologique en matiere de balanites a repetition. Elle souligne par ailleurs l'efficacite potentielle de l'immunotherapie specifique conduite avec un extrait de Candida albicans.
- Published
- 1999
- Full Text
- View/download PDF
7. Intérêt diagnostique et pronostique du TPA et de l'ACE pleural dans les pleurésies
- Author
-
H Larbre, N Schneider, D Perdu, and V Cliquenois
- Subjects
Gynecology ,medicine.medical_specialty ,biology ,Pleural effusion ,business.industry ,Biochemistry (medical) ,Clinical Biochemistry ,Respiratory disease ,medicine.disease ,Pleural disease ,Carcinoembryonic antigen ,Pleurisy ,medicine ,biology.protein ,Pleural fluid ,business - Abstract
resume Dans notre travail, nous avons etudie l'interet diagnostique et pronostique du tissue polypeptide antigen (TPA) et de l'antigene carcinoembryonnaire (ACE) en pathologie pleurale, compare au diagnostic cytologique. Les dosages pleuraux de ces marqueurs tumoraux ont ete realises chez 76 patients repartis en trois groupes : 31 patients avec une pleuresie benigne, 25 patients avec une pleuresie maligne et 20 patients avec une pleuresie d'origine indeterminee. L'analyse en courbe ROC met en evidence un leger avantage du TPA pleural sur l'ACE bien que cette superiorite ne soit pas statistiquement significative. La specificite des deux marqueurs est excellente, la sensibilite comparable a celle retrouvee par d'autres auteurs. De plus, les taux eleves des marqueurs retrouves chez des patients du groupe indetermine a cytologie negative ont permis de reclasser ces patients dans le groupe ≪ pleuresie tumorale ≫ et montrent donc l'interet d'associer le dosage des marqueurs a l'examen cytologique d'un liquide pleural dans le bilan de pleuresie.
- Published
- 1997
- Full Text
- View/download PDF
8. Allergènes du latex, antigènes spécifiques et réactions croisées
- Author
-
Frédéric Deschamps, J.F. Fontaine, F. Lavaud, and D. Perdu
- Subjects
Anesthesiology and Pain Medicine ,Immunology and Allergy - Abstract
Resume Les proteines du latex constituent un melange polyallergenique dont la composition est variable en fonction de parametres botaniques, techniques et immunologiques. Malgre des resultats parfois discordants, les tres nombreuses etudes portant sur l'identification des allergenes montrent le role de l'heveine et de son precurseur la proheveine, du facteur d'elongation du latex et des β glucosidases. L'existence d'allergenes croises avec d'autres vegetaux de familles botaniques parfois tres eloignees, en particulier les fruits, rend compte de la conservation interespeces de motifs proteiques tres voisins. Parmi ces allergenes croises, le lysozyme parait etre un panallergene vegetal, appartenant au groupe des proteines de stress.
- Published
- 1996
- Full Text
- View/download PDF
9. [Primary myxoid mediastinal liposarcoma]
- Author
-
J-M, Perotin, G, Deslee, D, Perdu, V, Cahn, P, Validire, S, Rubin, P, Magdeleinat, O, Toubas, and F, Lebargy
- Subjects
Young Adult ,Thoracotomy ,Antineoplastic Combined Chemotherapy Protocols ,Humans ,Female ,Radiotherapy, Adjuvant ,Magnetic Resonance Imaging ,Mediastinal Neoplasms ,Disease-Free Survival ,Liposarcoma, Myxoid ,Neoadjuvant Therapy - Abstract
Mediastinal liposarcomas (LPS) are rare tumours. We report a case of primary myxoid LPS in a 22-year-old woman suffering from cough, dyspnoea on exercise and asthenia for 3 weeks. Thoracic MRI showed a large tumour on the right side. After neoadjuvant chemotherapy, a complete resection was performed, followed by adjuvant thoracic irradiation. Eighteen months after the diagnosis, no sign of recurrence was detected. Mediastinal LPS include a heterogeneous group of bulky tumours, the progression of which depends on the histological type. The prognosis is dominated by the operability of the tumour. Adjuvant therapies are not established.
- Published
- 2010
10. A Colored Petri Net Model for the Assessment of the Management of a Distributed Intelligent System Designed with Cube Tool
- Author
-
D. Perdu
- Subjects
Computer science ,Distributed computing ,media_common.quotation_subject ,Intelligent decision support system ,Cube (algebra) ,Folding (DSP implementation) ,Petri net ,Net (mathematics) ,Representation (mathematics) ,Function (engineering) ,media_common - Abstract
Distributed Intelligent Systems (DIS) are, among other characteristics, geographically dispersed. A DIS will function properly and fulfill the tasks it has to perform only if the use of dispersed resources, processes and communications is correctly coordinated, that is if the system is appropriately managed. An approach is introduced to take into account this management aspect at an early stage of the design. The aim is to animate a DIS which has been defined statically with CUBE TOOL in order to get an assessment of its dynamical behavior before any implementation. Colored Petri Nets are used to model the system and to reduce the complexity of its representation by folding together identical substructures.
- Published
- 1991
- Full Text
- View/download PDF
11. Purpura vasculaire provoqué par l'injection de daltéparine
- Author
-
V. Salmon, D. Perdu, F. Lavaud, J.J. Adnet, and François Lebargy
- Subjects
Gynecology ,medicine.medical_specialty ,Purpura ,Anesthesiology and Pain Medicine ,Dalteparin sodium ,business.industry ,Vascular purpura ,medicine ,Immunology and Allergy ,medicine.symptom ,business ,medicine.drug - Abstract
Resume Une observation de purpura vasculaire apres injection de dalteparine au cours d'un cancer bronchique complique de phlebite est rapportee. Le purpura cedait apres arret de la dalteparine, alors qu'aucune autre cause de purpura n'etait mise en evidence. L'intradermo-reaction a la dalteparine positive evoquait un mecanisme d'hypersensibilite, mecanisme conforte par la notion d'une prescription anterieure a la toxidermie de la dalteparine. Un heparinoide de synthese, le lomoparan, put etre substitue a la dalteparine sans intolerance. Cette observation, tres rarement decrite, souligne la necessite d'une surveillance accrue des heparines de bas poids moleculaire. Ces molecules, de plus en plus prescrites dans la maladie thromboembolique, sont pourant a l'origine d'hemorragies et d'effets secondaires immunoallergiques, surtout des thrombopenies mais aussi des toxidermies, comme celle decrite dans notre observation. Les heparinoides de synthese pourraient constituer une alternative therapeutique.
- Published
- 1999
- Full Text
- View/download PDF
12. Reintegration to Normal Living Index in a population of community-dwelling people with slowly muscular diseases
- Author
-
M P Chaunu, E. Regrain, J.-C. Merol, Amandine Rapin, D. Gaillard, L. Percebois-Macadré, G. Belassian, J.-M. Coulon, D. Perdu, François Boyer, Redha Taiar, F. Carre-Pigeon, V. Bombart, M. Toussaint-Thorin, and Pierre Nazeyrollas
- Subjects
Gerontology ,education.field_of_study ,Index (economics) ,business.industry ,Questionnaire ,Muscular dystrophies ,Population ,Rehabilitation ,Reproducibility ,Scale ,Validity ,Neuromuscular diseases ,Medicine ,Orthopedics and Sports Medicine ,business ,education - Published
- 2013
- Full Text
- View/download PDF
13. Erythema multiforme due to pyrazinamide
- Author
-
B. Kalis, A. Prevost, F. Lavaud, M. P. Cambie, D. Perdu, K. Barhoum, Frédéric Deschamps, and E. Bongrain
- Subjects
Male ,Drug ,medicine.medical_specialty ,Tuberculosis ,media_common.quotation_subject ,medicine.medical_treatment ,Immunology ,Antitubercular Agents ,medicine ,Humans ,Immunology and Allergy ,Antipyretic ,Erythema multiforme ,skin and connective tissue diseases ,Aged ,media_common ,Erythema Multiforme ,Chemotherapy ,integumentary system ,business.industry ,Pyrazinamide ,medicine.disease ,Dermatology ,Discontinuation ,business ,Complication ,medicine.drug - Abstract
Drug-induced erythema multiforme is reported with many antimicrobial and antipyretic medications. We present one patient who experienced erythema multiforme and urticaria after administration of pyrazinamide for treatment of cutaneous tuberculosis. The side-effects of pyrazinamide include hepatic or dermatologic disorders, but erythema multiforme has not yet, to our knowledge, been described. Clinical features and discontinuation and reintroduction of the drug led us to consider pyrazinamide the cause of the erythema multiforme, but allergologic studies remained negative, except for the presence of circulating immune complexes. The mechanism of this eruption remains obscure, and definite withdrawal of pyrazinamide seems to be the best therapeutic choice.
- Published
- 1996
- Full Text
- View/download PDF
14. Cystite hématurique due à une allergie alimentaire
- Author
-
H. Vallerand, Y. Youinou, F. Lavaud, D. Perdu, J.P. Melin, and A. Prevost
- Subjects
Anesthesiology and Pain Medicine ,Immunology and Allergy - Abstract
Resume Les cystites allergiques demeurent une pathologie controversee et sont tout au moins exceptionnelles. Parfois un allergene alimentaire est implique. Les auteurs rapportent deux observations de cystites hematuriques qui ont pu etre rattachees a une allergie alimentaire. Dans les deux observations, une sensibilisation aux trophallergenes est prouvee (le lait de vache pour la premiere, le blanc d'œuf et les crustaces pour la seconde). Le diagnostic de cystite par allergie alimentaire est retenu sur l'evolution des symptomes apres plus d'un an de recul sous regimes d'exclusion et de reintroduction. L'apport therapeutique des nouveaux antihistaminiques et du cromoglycate disodique est discute.
- Published
- 1994
- Full Text
- View/download PDF
15. Phase II trial of paclitaxel and carboplatin in metastatic small-cell lung cancer: a Groupe Français de Pneumo-Cancérologie study
- Author
-
C. Penot-Ragon, D. Paillotin, P. Balmes, P. Delaval, François Blanchon, J. F. Muir, D. Perdu, Hervé Lena, Sylvie Gouva, R. Poirier, P. Pommier de Santi, Pascal Thomas, O. Castelnau, Jean-Pierre Kleisbauer, and Gilles Robinet
- Subjects
Adult ,Male ,Cancer Research ,medicine.medical_specialty ,Lung Neoplasms ,Neutropenia ,Paclitaxel ,medicine.medical_treatment ,Small-cell carcinoma ,Gastroenterology ,Carboplatin ,chemistry.chemical_compound ,Internal medicine ,Antineoplastic Combined Chemotherapy Protocols ,Medicine ,Humans ,Carcinoma, Small Cell ,Neoplasm Metastasis ,Lung cancer ,Aged ,Chemotherapy ,business.industry ,Area under the curve ,Anemia ,Middle Aged ,medicine.disease ,Survival Analysis ,Thrombocytopenia ,Surgery ,Treatment Outcome ,Oncology ,chemistry ,Prednisolone ,Premedication ,Female ,business ,Progressive disease ,medicine.drug - Abstract
PURPOSE: To evaluate the efficacy and safety of paclitaxel and carboplatin in the treatment of previously untreated patients with metastatic small-cell lung cancer (SCLC). PATIENTS AND METHODS: Eligible patients were aged 18 to 75 years with an Eastern Cooperative Oncology Group (ECOG) score ≤ 2 and life expectancy ≥ 12 weeks. Paclitaxel (200 mg/m2) was infused over 3 hours, before carboplatin (area under the curve [AUC] 6; Calvert formula) infused over 1 hour, once every 3 weeks for six cycles maximum. Prednisolone, dexchlorpheniramine, and ranitidine were standard premedication. Response to treatment was assessed every two cycles, and nonresponding patients were withdrawn from the trial to receive standard chemotherapy. RESULTS: Of the 50 patients entering the study, 48 and 46 patients were assessable for toxicity and response, respectively. The overall response rate was 65%, with complete responses in three patients. Five patients had stable disease (11%) and 11 patients experienced progressive disease (24%). Median survival was 38 weeks, and median duration of response was 20 weeks. One-year survival was 22.5%. For a total of 232 cycles, grade 3 and 4 toxicity was 33% for neutropenia, 3.5% for thrombocytopenia, and 4% for anemia. Four patients had neutropenic fever (one toxic death). Nonhematologic toxicity was mainly grade 1 and 2 paresthesia (21% of patients); grade 3 myalgia/arthralgia was observed in 6.5% of patients. CONCLUSION: First-line chemotherapy with paclitaxel and carboplatin in metastatic SCLC achieved a response rate and survival similar to standard regimens. With 1-day administration and a tolerable toxicity profile, this combination merits further investigation.
- Published
- 2001
16. [Pulmonary infections other than AIDS]
- Author
-
D, Perdu and F, Lebargy
- Subjects
Immunosuppression Therapy ,Lung Diseases ,Immunocompromised Host ,Lung Diseases, Parasitic ,Risk Factors ,Transplantation Immunology ,Virus Diseases ,Decision Trees ,Humans ,Algorithms - Published
- 1998
17. Perception de l’intégration à la vie normale des personnes atteintes de maladies neuromusculaires lentement progressives
- Author
-
V. Bombart, Amandine Rapin, M. Toussaint-Thorin, Redha Taiar, Pierre Nazeyrollas, L. Percebois-Macadré, D. Perdu, D. Gaillard, F. Carre-Pigeon, E. Regrain, J.-M. Coulon, M P Chaunu, François Boyer, G. Belassian, and J.-C. Merol
- Subjects
Questionnaire ,Rehabilitation ,Orthopedics and Sports Medicine ,Échelle ,Dystrophies musculaires ,Reproductibilité ,Maladie neuromusculaire ,Validité - Abstract
Satisfaction des attentes ; Satisfaction Objectif .– La relation entre les attentes des patients avant arthroplastie totale de hanche (ATH) et la satisfaction postoperatoire est mal comprise. L’objectif de ce travail etait d’evaluer les facteurs associes a la satisfaction globale et a la satisfaction des attentes 1 an apres ATH. Methodes.– Dans une precedente etude [1], les attentes de 132 patients en attente d’ATH et de leurs chirurgiens respectifs etaient evaluees par le « Hospital for Special Surgery Total Hip Replacement Expectations Survey » (THR survey). Un an apres l’intervention, 123 patients repondaient a un questionnaire sur la satisfaction de leurs attentes (THR survey), leur satisfaction globale, leur fonction (Womac) et leur qualite de vie (SF-12). Des analyses uniet multivariees etaient realisees pour evaluer les determinants de la satisfaction globale et de la satisfaction des attentes. Resultats.– Les attentes des chirurgiens etaient plus realistes que celles des patients concernant la persistance de douleurs nocturnes et le besoin d’aide a la marche. Les patients et les chirurgiens avaient des attentes trop optimistes concernant la reprise des activites sportives et professionnelles, l’amelioration des activites sexuelles, la possibilite de se chausser ou de se couper les ongles de pied. Chez les patients satisfaits (n = 113), la composante psychologique du SF12 preoperatoire etait plus elevee, et les attentes des chirurgiens plus optimistes. La satisfaction des attentes etait le seul facteur associe de facon significative a la satisfaction globale (OR ajuste 1,08, IC a 95% [1,04 ; 1,12]). La satisfaction des attentes pouvait etre predite en preoperatoire par un âge peu eleve (coefficient de regression –0,55 [–0,88 ; –0,21]), un meilleur etat psychologique (0,56 [0,14 ; 0,99]) et unemeilleure fonction (–0,96 [–1,82 ; –0,1]). Apres la chirurgie, la recuperation fonctionnelle etait le seul determinant de la satisfaction des attentes (–2,10 [–2,79 ; –1,42]). Discussion.– Quelles ques soient les attentes des patients avant ATH, seule leur satisfaction determine la satisfaction globale 1 an apres l’intervention. Les chirurgiens, dont les attentes paraissent realistes, pourraient mieux communiquer avec les patients de facon a moderer leurs attentes concernant certaines activites. Reference [1] Jourdan C, et al. Comparison of patient and surgeon expectations of total hip arthroplasty. PLoS One 2012;7(1):e30195.
- Published
- 2013
- Full Text
- View/download PDF
18. [Carcinoid thymus tumor at an advanced age: diagnostic value of mediastinal needle biopsy with computerized tomography]
- Author
-
D, Perdu, F, Lavaud, M, Masure, A, Prévost, G, Delépine, B, Baehrel, and J J, Adnet
- Subjects
Aged, 80 and over ,Male ,Fatal Outcome ,Biopsy, Needle ,Age Factors ,Humans ,Carcinoid Tumor ,Thymus Neoplasms ,Radiography, Interventional ,Tomography, X-Ray Computed ,Aged - Abstract
Carcinoid tumour of the thymus is a rare neuroendocrine tumour particularly at an advanced age. The authors report a case of a mediastinal mass in a man aged 85, the mass had remained asymptomatic for a long time. It was decided to achieve a diagnosis because the tumour was causing local compression: a mediastinal needle biopsy under computerised tomographic control confirmed that this was a carcinoid tumour and a study of the biopsy material using an electron microscope showed neurosecretory granules. A sternotomy enabled the tumour to be excised but a post-operative Pseudomonas pneumonia led to the death of the patient. This case underlines the diagnostic place of mediastinal needle biopsy in the presence of a mediastinal tumour. The technique can be carried out under computerised tomography or ultrasonography and this can be associated with a study of the biopsy specimen using electron microscopy which enables the diagnosis to be made before any therapeutic decisions. The treatment of choice of a carcinoid tumour of the thymus is surgery which confirms the tumour limits and also its thymic origin. Tumour excision can be completed using radiotherapy or even chemotherapy.
- Published
- 1996
19. Baker's asthma related to soybean lecithin exposure
- Author
-
A. Prevost, D. Perdu, Cossart C, F. Lavaud, Passemard F, and H. Vallerand
- Subjects
Adult ,Male ,Allergy ,food.ingredient ,Immunology ,medicine.disease_cause ,Lecithin ,Bronchial Provocation Tests ,food ,Allergen ,Radioallergosorbent Test ,immune system diseases ,Forced Expiratory Volume ,Occupational Exposure ,medicine ,Immunology and Allergy ,Humans ,Cooking ,Sensitization ,Asthma ,Skin Tests ,medicine.diagnostic_test ,business.industry ,Radioallergosorbent test ,food and beverages ,respiratory system ,Immunoglobulin E ,medicine.disease ,respiratory tract diseases ,Occupational Diseases ,medicine.anatomical_structure ,Phosphatidylcholines ,Bronchial challenge test ,Soybeans ,business ,Occupational asthma - Abstract
We report two cases of soybean-lecithin-induced asthma in bakers. The patients experienced clinical symptoms in relation to an occupational exposure to this additive. Skin tests were positive with soybean lecithin, RAST showed a sensitization to soybean, and bronchial challenge tests were positive for a dilution of 10(-3) with this allergen. The same tests remained negative among healthy and asthmatic controls. Soybean lecithin, a common additive in bakery, must be added to the list of numerous aeroallergens involved in baker's asthma.
- Published
- 1994
20. [Importance of serum TPA determination in bronchopulmonary cancer. A comparative study of CEA, CA 19.9 and NSE]
- Author
-
A, Prévost, F, Passemard, D, Perdu, H, Vallerand, F, Deschamps, F, Lavaud, and H, Larbre
- Subjects
Lung Diseases ,Lung Neoplasms ,CA-19-9 Antigen ,Bronchial Neoplasms ,Bronchial Diseases ,Carcinoid Tumor ,Adenocarcinoma ,Carcinoembryonic Antigen ,Diagnosis, Differential ,Carcinoma, Bronchogenic ,Antigens, Neoplasm ,Carcinoma, Non-Small-Cell Lung ,Phosphopyruvate Hydratase ,Biomarkers, Tumor ,Carcinoma, Squamous Cell ,Humans ,Tissue Polypeptide Antigen ,Carcinoma, Small Cell ,Peptides - Abstract
This study concerns 45 patients group one suffering from broncho-pulmonary cancer, the diagnosis was obtained by bronchial biopsies or by transparietal puncture using a scanner: there were 35 non-small cell bronchial carcinomas (CNPC) and 10 small cell bronchial cancers (CPC). The control patients (99 patients) were divided up as follows: 44 pleuro-pulmonary infections (group two) and 55 with respiratory failure of various causes other than infectious episodes (group three). In group one the level for TPA was positive in 30 cases (the threshold value was 90 units per litre), 9 for CA 19.9, 7 for ACE and 9 for NSE. The overall sensitivity was thus better for TPA. There was no correlation between TPA and type of tumour histology nor between the different markers. Their association did not improve the sensitivity. The NSE however, remained the most sensitive test for the diagnosis of CPC with six positive tests out of ten. In the control population, the specificity of TPA (66%) was less than that of ACE (100%) or of CA 19.9 (94%) and the false positives were significantly more numerous in group two: 21 patients had a positive test compared to only 12 in group three. Finally we noticed an increase in the level of TPA contrary to other markers, as a function of the extent of the disease from the carcinoma (CNPC unique). The TPA is thus the most sensitive and it turns out to be better reflector to the extent of the tumour disease than either ACE, CA 19.9 or NSE but this applies uniquely to non-small cell carcinoma.
- Published
- 1994
21. [Bronchial epidermoid carcinoma with unusual disclosure]
- Author
-
D, Perdu, E, Varini, B, Louis, F, Lavaud, A, Prevost, E, Bongrain, E, Arav, and M D, Diebold
- Subjects
Pancreatic Neoplasms ,Carcinoma, Bronchogenic ,Fatal Outcome ,Lung Neoplasms ,Carcinoma, Squamous Cell ,Humans ,Female ,Middle Aged ,Tomography, X-Ray Computed - Abstract
Dissemination has often occurred before the diagnosis of bronchopulmonary cancer. Pancreatic metastases are exceptional and are very rarely the revealing manifestation. The authors report a case of a tumour of the pancreas which led to the discover of an bronchogenic epidermoid carcinoma. The relationship between these two tumours lead to the proposed hypothesis of pancreatic metastasis of a bronchogenic carcinoma. Although this situation is rare, the preoperative work-up for bronchogenic carcinoma should include computed tomography of the pancreas if the abdominal echography does not allow complete visualization of the pancreas in cases with suggestive digestive disorders. If a tumour is observed in the pancreas, scan-guided needle biopsy should be performed to enable the histological examination.
- Published
- 1994
22. [Bronchial biopsy, curative treatment for cancer in situ?]
- Author
-
D, Perdu, A, Prévost, H, Vallerand, F, Lavaud, B, Baehrel, and T, Caulet
- Subjects
Male ,Carcinoma, Bronchogenic ,Lung Neoplasms ,Biopsy ,Bronchoscopy ,Humans ,Pneumonectomy ,Carcinoma in Situ ,Aged - Abstract
Bronchial carcinoma in situ is an intra-epithelial proliferation of tumour which does not cross the basement membrane and is asymptomatic. The evidence for this cancer often rests on a biopsy carried out on a bronchus which may show simple inflammation or may even be normal. We report a new observation on a bronchial carcinoma in situ which was completely ablated after a bronchial biopsy. However surgery remains the first form of treatment for bronchial cancer. If the patient is inoperable, endobroncho-cryotherapy, radiotherapy or phototherapy may be tried but tumour recurrence remains a possibility.
- Published
- 1993
23. [Detergent enzymes: has the risk of occupational sensitization disappeared?]
- Author
-
D, Perdu, F, Lavaud, C, Cossart, S, Legrele, F, Passemard, G, Deltour, and J M, Dubois de Montreynaud
- Subjects
Adult ,Drug Hypersensitivity ,Male ,Occupational Diseases ,Radioallergosorbent Test ,Detergents ,Humans ,Middle Aged ,Asthma ,Peptide Hydrolases ,Skin Tests - Abstract
Occupational allergy to enzyme detergents had almost disappeared by the use of preventive measures, both individually and in industries. The occurrence of 8 new cases of asthma in a detergent factory has led to a prospective clinical and aetiological enquiry. Although there was no documentation using the specific provocation test or by measuring respiratory function whilst at work, the occupational character of this asthma seemed possible after taking a history. Sensitization to the enzymes used (Savinase, Maxatase and Biozym P 300 S) was shown by skin tests (8 positive to all the enzymes) and the level of specific IgE to Rast (8 times greater than class 3 for Savinase and Maxitase) and for HBDT for Maxatase and Biozym P 300 S (greater than 50% in 8 patients). From another stand point the incomplete application of preventive measures within the factory did not seem to totally explain the origin of this sensitization. In fact, it was the study of the morphology of the enzyme grains, which had been introduced into the factory which helped us to explain the mechanism. In effect it was the capsules of the grain which were fissured and thus allowed allergen contact. The replacement of these grains whose envelope was intact, led to the disappearance of the symptoms and confirmed our hypothesis. There remains a continuing risk from occupational sensitization to asthma and it is suggested that there is continued collaboration between the medical profession and industry.
- Published
- 1992
24. Combination chemotherapy with cisplatin, etoposide and gallium chloride for lung cancer: individual adaptation of doses
- Author
-
P, Collery, M, Morel, B, Desoize, H, Millart, D, Perdu, A, Prevost, H, Vallerand, C, Pechery, H, Choisy, and J C, Etienne
- Subjects
Lung Neoplasms ,Carcinoma, Non-Small-Cell Lung ,Antineoplastic Combined Chemotherapy Protocols ,Carcinoma, Squamous Cell ,Humans ,Gallium ,Gallium Radioisotopes ,Adenocarcinoma ,Carcinoma, Small Cell ,Cisplatin ,Middle Aged ,Drug Administration Schedule ,Etoposide - Abstract
Twelve inoperable lung cancer patients were treated with a combination chemotherapy of cisplatinum (CDDP) and etoposide (VP16), as a continuous infusion for 5 days, every 21 days, and with a daily oral administration of GaCl3. Dosages of CDDP and VP16 were adapted in order to obtain an area under the curve (AUC) of 80,000 micrograms l-1.h for plasma total platinum and of 200 mumol.l-1 h for plasma VP16 during each 120 h infusion. GaCl3 was given at the dosage of 400 mg/24h from the time of diagnosis at least until the evaluation after 3 courses of chemotherapy. An objective response was observed in 5 non small cell (NSCLC) lung cancer patients (group 1) and 3 small cell (SCLC) lung cancer patients (group 2). In the other 4 patients with a NSCLC no partial response was noted (group 3). No significant difference in area under the curve (AUC) was noted between the 3 groups, either for plasma total platinum (group 1 = 89,598 +/- 20,843 micrograms l-1.h; group 2 = 88,081 +/- 15,431 micrograms l-1.h; group 3 = 83,820 +/- 13,455 micrograms l-1.h), or for VP16 (group 1 = 227 +/- 41 mumol.l-1 h; group 2 = 217 +/- 29 mumol.l-1.h and group 3 = 211 +/- 30 mumol.l-1.h). The maximal plasma Ga concentrations were 244 +/- 34 micrograms/l in group 1, 112 +/- 57 micrograms/l in group 3 (p less than 0.005) and 243 +/- 132 micrograms/l in group 2. It was then decided to increase the dose of GaCl3 in the further non-responding patients. In 6 responders, 3 additional courses of this combination chemotherapy could have been given without major toxicity, allowing a much more important decrease in the tumor volume in 4 of them. This schedule of treatment should permit the chemotherapy to continue for longer than 6 courses, in order to improve the survival time.
- Published
- 1991
25. Occupational Origin of ACE Inhibitor Cough
- Author
-
Frédéric Deschamps, A. Prevost, F Lavaud, and D Perdu
- Subjects
business.industry ,ACE inhibitor ,Public Health, Environmental and Occupational Health ,MEDLINE ,Medicine ,Pharmacology ,business ,Drug industry ,medicine.drug - Published
- 1995
- Full Text
- View/download PDF
26. Phase II trial of taxol and paraplatin in metastatic small cell lung cancer (SCLC). A G.F.P.C. Study (Groupe Francais de Pneumo-Cancerologie)
- Author
-
R. Poirier, Jean-Pierre Kleisbauer, P. Delaval, P. Pommier de Santi, Pascal Thomas, F. Blanchon, J Clavier, D. Paillotin, D. Perdu, Hervé Lena, and Gilles Robinet
- Subjects
Pulmonary and Respiratory Medicine ,Oncology ,Cancer Research ,medicine.medical_specialty ,business.industry ,Internal medicine ,medicine ,Non small cell ,business - Published
- 2000
- Full Text
- View/download PDF
27. Combination chemotherapy with cisplatin, etoposide and gallium chloride for lung cancer: Individual adaptation of doses
- Author
-
H Millart, M Morel, A Prevost, P Collery, D Perdu, and B Desoize
- Subjects
Pulmonary and Respiratory Medicine ,Oncology ,Cancer Research ,medicine.medical_specialty ,business.industry ,Gallium chloride ,Combination chemotherapy ,medicine.disease ,Internal medicine ,Cisplatin/etoposide ,medicine ,business ,Lung cancer - Published
- 1992
- Full Text
- View/download PDF
28. Simple Aspiration versus Drainage for Complete Pneumothorax: A Randomized Noninferiority Trial.
- Author
-
Marx T, Joly LM, Parmentier AL, Pretalli JB, Puyraveau M, Meurice JC, Schmidt J, Tiffet O, Ferretti G, Lauque D, Honnart D, Al Freijat F, Dubart AE, Grandpierre RG, Viallon A, Perdu D, Roy PM, El Cadi T, Bronet N, Duncan G, Cardot G, Lestavel P, Mauny F, and Desmettre T
- Subjects
- Adult, Humans, Prospective Studies, Neoplasm Recurrence, Local, Drainage methods, Chest Tubes, Chest Pain, Pneumothorax surgery
- Abstract
Rationale: Management of first episodes of primary spontaneous pneumothorax remains the subject of debate. Objectives: To determine whether first-line simple aspiration is noninferior to first-line chest tube drainage for lung expansion in patients with complete primary spontaneous pneumothorax. Methods: We conducted a prospective, open-label, randomized noninferiority trial. Adults aged 18-50 years with complete primary spontaneous pneumothorax (total separation of the lung from the chest wall), recruited at 31 French hospitals from 2009 to 2015, received simple aspiration ( n = 200) or chest tube drainage ( n = 202) as first-line treatment. The primary outcome was pulmonary expansion 24 hours after the procedure. Secondary outcomes were tolerance of treatment, occurrence of adverse events, and recurrence of pneumothorax within 1 year. Substantial discordance in the numerical inputs used for trial planning and the actual trial rates of the primary outcome resulted in a reevaluation of the trial analysis plan. Measurement and Main Results: Treatment failure occurred in 29% in the aspiration group and 18% in the chest tube drainage group (difference in failure rate, 0.113; 95% confidence interval [CI], 0.026-0.200). The aspiration group experienced less pain overall (mean difference, -1.4; 95% CI, -1.89, -0.91), less pain limiting breathing (frequency difference, -0.18; 95% CI, -0.27, -0.09), and less kinking of the device (frequency difference, -0.05; 95% CI, -0.09, -0.01). Recurrence of pneumothorax was 20% in this group versus 27% in the drainage group (frequency difference, -0.07; 95% CI, -0.16, +0.02). Conclusions: First-line management of complete primary spontaneous pneumothorax with simple aspiration had a higher failure rate than chest tube drainage but was better tolerated with fewer adverse events. Clinical trial registered with www.clinicaltrials.gov (NCT01008228).
- Published
- 2023
- Full Text
- View/download PDF
29. Insomnia in adults with cystic fibrosis: strong association with anxiety/depression and impaired quality of life.
- Author
-
Mulette P, Ravoninjatovo B, Guguen C, Barbe C, Ancel J, Dury S, Dumazet A, Perdu D, Perotin JM, Guillard T, Lebargy F, Deslee G, and Launois C
- Subjects
- Adult, Anxiety complications, Cystic Fibrosis physiopathology, Depression complications, Female, France, Humans, Male, Pain, Psychiatric Status Rating Scales, Respiratory Function Tests, Severity of Illness Index, Sleep, Sleep Initiation and Maintenance Disorders physiopathology, Surveys and Questionnaires, Young Adult, Cystic Fibrosis complications, Cystic Fibrosis psychology, Quality of Life, Sleep Initiation and Maintenance Disorders complications, Sleep Initiation and Maintenance Disorders psychology
- Abstract
Background: While sleep disruption is a common complaint among children with cystic fibrosis (CF), only a few studies have investigated insomnia in adults. The aim of this study was to identify factors associated with insomnia in clinically stable adult CF patients., Methods: Twenty-eight CF patients (18M/10F), with a median age of 27 (22-34) (median (interquartile range) years and a median of forced expiratory volume in one second of 72 (39-93) % predicted completed questionnaires on insomnia (Insomnia Severity Index, ISI), sleep quality (PSQI), daytime sleepiness (Epworth), restless legs syndrome (IRLS), pain (NRS), anxiety/depression (HAD) and quality of life (CFQ-R 14+). Respiratory assessment data, including symptoms, sputum analysis, arterial blood gases, 6-min walking test, pulmonary function tests and polysomnographic variables, were also analyzed., Results: Forty-three percent of patients were insomniac (ISI > 7). Compared with non-insomniac patients (ISI ≤ 7), insomniac patients had more severely impaired quality of life and a higher HAD score: median anxiety score of 9 (8-11) vs 4 (3-6) (p < 0.0001), median depression score of 7 (5-10) vs 1 (1-4) (p < 0.001), with a positive correlation between ISI and HAD anxiety/depression scores (r = 0.702/r = 0.701, respectively, p < 0.0001). Insomnia was also associated with mMRC dyspnea scale ≥ 2, restless legs syndrome, pain and lower SpO
2 during sleep., Conclusions: The strong association between insomnia, impaired quality of life and increased HAD score should prompt physicians to be particularly attentive to the management of anxiety and depression in adult CF patients with insomnia., Trial Registration: On clinicaltrials.gov (NCT02924818, date of registration: October 5, 2016).- Published
- 2021
- Full Text
- View/download PDF
30. [Systemic lupus erythematosus presenting as severe alveolar hypoventilation and the shrinking lung syndrome].
- Author
-
Ammar Y, Launois C, Perotin JM, Dury S, Servettaz A, Perdu D, Vallerand H, Nardi J, Boulagnon-Rombi C, Pluot M, Lebargy F, and Deslee G
- Subjects
- Aged, Diagnosis, Differential, Humans, Male, Radiography, Thoracic, Severity of Illness Index, Syndrome, Hypoventilation diagnosis, Hypoventilation etiology, Lung Diseases complications, Lung Diseases diagnosis, Lupus Erythematosus, Systemic complications, Lupus Erythematosus, Systemic diagnosis
- Abstract
Introduction: The shrinking lung syndrome (SLS) is a rare complication of systemic lupus erythematosus., Case Report: A 69-year-old man presented with exertional dyspnoea, muscle weakness, and weight loss of 15kg in 6months. Pulmonary function tests revealed a restrictive lung disorder, with a dramatic decrease in maximal inspiratory pressure (17% of theoretical value), and alveolar hypoventilation (pH 7.43; PaCO
2 55mmHg). A thoracic CT-scan showed bilateral diaphragmatic elevation. The creatinine phophokinase level was increased at 280U/L. Progress was marked by a rapidly increasing respiratory acidosis (pH 7.24, PaCO2 109mmHg) requiring invasive ventilation. Auto-immune studies revealed positive anti-nuclear antibodies (1/800) and positive anti-native DNA antibody at 45U/L. Treatment with systemic corticosteroids led to an initial improvement but it was not possible to discontinue mechanical ventilation. The outcome was fatal. Autopsy did not reveal any other cause and a diagnosis of the SLS associated with lupus was confirmed., Conclusion: The interesting features of this case report consist of: 1) the presentation of the SLS as an alveolar hypoventilation with a fatal outcome, 2) the presentation of systemic lupus as SLS., (Copyright © 2017 SPLF. Published by Elsevier Masson SAS. All rights reserved.)- Published
- 2017
- Full Text
- View/download PDF
31. Endobronchial actinomycosis associated with foreign body: four cases and a review of the literature.
- Author
-
Chouabe S, Perdu D, Deslée G, Milosevic D, Marque E, and Lebargy F
- Subjects
- Aged, Female, Humans, Male, Middle Aged, Actinomycosis etiology, Bronchi, Bronchial Diseases etiology, Foreign Bodies complications
- Abstract
Four cases of primary endobronchial actinomycosis associated with an inhaled foreign body are described. In the light of these cases and those previously reported in the literature, we describe the main features of this uncommon association. All patients were > 55 years old, were predominantly men, and were usually in a debilitated state. In > 50% of cases, the clinical presentation was suggestive of lung cancer. Thoracic CT rarely revealed a foreign body, but the granulomatous reaction of the bronchial wall was sometimes suggestive of bronchial thickening. Sulfur granules identified on bronchial biopsies were highly suggestive of actinomycosis in most cases, but microbiological culture findings were usually negative. Antibiotics generally ensure good recovery. Extraction of the foreign body was delayed after antibiotic therapy in one half of cases, suggesting the need for endoscopic follow-up in bronchial actinomycosis.
- Published
- 2002
- Full Text
- View/download PDF
32. Phase II trial of paclitaxel and carboplatin in metastatic small-cell lung cancer: a Groupe Français de Pneumo-Cancérologie study.
- Author
-
Thomas P, Castelnau O, Paillotin D, Léna H, Robinet G, Muir JF, Delaval P, Gouva S, Balmes P, Blanchon F, Perdu D, Poirier R, Pommier De Santi P, Penot-Ragon C, and Kleisbauer JP
- Subjects
- Adult, Aged, Anemia chemically induced, Carboplatin administration & dosage, Carboplatin adverse effects, Carcinoma, Small Cell secondary, Female, Humans, Lung Neoplasms pathology, Male, Middle Aged, Neoplasm Metastasis, Neutropenia chemically induced, Paclitaxel administration & dosage, Paclitaxel adverse effects, Survival Analysis, Thrombocytopenia chemically induced, Treatment Outcome, Antineoplastic Combined Chemotherapy Protocols therapeutic use, Carcinoma, Small Cell drug therapy, Lung Neoplasms drug therapy
- Abstract
Purpose: To evaluate the efficacy and safety of paclitaxel and carboplatin in the treatment of previously untreated patients with metastatic small-cell lung cancer (SCLC)., Patients and Methods: Eligible patients were aged 18 to 75 years with an Eastern Cooperative Oncology Group (ECOG) score < or = 2 and life expectancy > or = 12 weeks. Paclitaxel (200 mg/m(2)) was infused over 3 hours, before carboplatin (area under the curve [AUC] 6; Calvert formula) infused over 1 hour, once every 3 weeks for six cycles maximum. Prednisolone, dexchlorpheniramine, and ranitidine were standard premedication. Response to treatment was assessed every two cycles, and nonresponding patients were withdrawn from the trial to receive standard chemotherapy., Results: Of the 50 patients entering the study, 48 and 46 patients were assessable for toxicity and response, respectively. The overall response rate was 65%, with complete responses in three patients. Five patients had stable disease (11%) and 11 patients experienced progressive disease (24%). Median survival was 38 weeks, and median duration of response was 20 weeks. One-year survival was 22.5%. For a total of 232 cycles, grade 3 and 4 toxicity was 33% for neutropenia, 3.5% for thrombocytopenia, and 4% for anemia. Four patients had neutropenic fever (one toxic death). Nonhematologic toxicity was mainly grade 1 and 2 paresthesia (21% of patients); grade 3 myalgia/arthralgia was observed in 6.5% of patients., Conclusion: First-line chemotherapy with paclitaxel and carboplatin in metastatic SCLC achieved a response rate and survival similar to standard regimens. With 1-day administration and a tolerable toxicity profile, this combination merits further investigation.
- Published
- 2001
- Full Text
- View/download PDF
33. [Pulmonary infections other than AIDS].
- Author
-
Perdu D and Lebargy F
- Subjects
- Algorithms, Decision Trees, Humans, Lung Diseases diagnosis, Lung Diseases drug therapy, Lung Diseases microbiology, Lung Diseases, Parasitic diagnosis, Lung Diseases, Parasitic drug therapy, Lung Diseases, Parasitic parasitology, Risk Factors, Virus Diseases diagnosis, Virus Diseases drug therapy, Virus Diseases virology, Immunocompromised Host, Immunosuppression Therapy adverse effects, Lung Diseases etiology, Lung Diseases, Parasitic etiology, Transplantation Immunology, Virus Diseases etiology
- Published
- 1998
34. Crossreactions involving natural rubber latex.
- Author
-
Lavaud F, Sabouraud D, Deschamps F, and Perdu D
- Subjects
- Humans, Cross Reactions immunology, Latex immunology
- Published
- 1997
- Full Text
- View/download PDF
35. [Carcinoid thymus tumor at an advanced age: diagnostic value of mediastinal needle biopsy with computerized tomography].
- Author
-
Perdu D, Lavaud F, Masure M, Prévost A, Delépine G, Baehrel B, and Adnet JJ
- Subjects
- Age Factors, Aged, Aged, 80 and over, Carcinoid Tumor diagnostic imaging, Carcinoid Tumor surgery, Fatal Outcome, Humans, Male, Radiography, Interventional methods, Thymus Neoplasms diagnostic imaging, Thymus Neoplasms surgery, Tomography, X-Ray Computed methods, Biopsy, Needle methods, Carcinoid Tumor pathology, Thymus Neoplasms pathology
- Abstract
Carcinoid tumour of the thymus is a rare neuroendocrine tumour particularly at an advanced age. The authors report a case of a mediastinal mass in a man aged 85, the mass had remained asymptomatic for a long time. It was decided to achieve a diagnosis because the tumour was causing local compression: a mediastinal needle biopsy under computerised tomographic control confirmed that this was a carcinoid tumour and a study of the biopsy material using an electron microscope showed neurosecretory granules. A sternotomy enabled the tumour to be excised but a post-operative Pseudomonas pneumonia led to the death of the patient. This case underlines the diagnostic place of mediastinal needle biopsy in the presence of a mediastinal tumour. The technique can be carried out under computerised tomography or ultrasonography and this can be associated with a study of the biopsy specimen using electron microscopy which enables the diagnosis to be made before any therapeutic decisions. The treatment of choice of a carcinoid tumour of the thymus is surgery which confirms the tumour limits and also its thymic origin. Tumour excision can be completed using radiotherapy or even chemotherapy.
- Published
- 1996
36. Nicotine transdermal therapeutic system patch and anaphylactoid reaction after a wasp sting.
- Author
-
Lavaud F, Prevost A, Perdu D, Vallerand H, Deschamps F, and Wong T
- Subjects
- Administration, Cutaneous, Animals, Humans, Male, Middle Aged, Anaphylaxis etiology, Insect Bites and Stings complications, Nicotine adverse effects, Wasps
- Published
- 1994
- Full Text
- View/download PDF
37. [Temporary oligoclonal gammapathy and lung disease in bird breeders].
- Author
-
Perdu D, Gillery P, Prevost A, Lavaud F, and Maquart FX
- Subjects
- Adrenal Cortex Hormones therapeutic use, Adult, Bird Fancier's Lung drug therapy, Bird Fancier's Lung immunology, Dysgammaglobulinemia immunology, Electrophoresis, Agar Gel, Female, Humans, Bird Fancier's Lung complications, Dysgammaglobulinemia etiology
- Published
- 1994
38. Baker's asthma related to soybean lecithin exposure.
- Author
-
Lavaud F, Perdu D, Prévost A, Vallerand H, Cossart C, and Passemard F
- Subjects
- Adult, Asthma diagnosis, Asthma physiopathology, Bronchial Provocation Tests, Forced Expiratory Volume, Humans, Immunoglobulin E immunology, Male, Occupational Diseases diagnosis, Occupational Diseases physiopathology, Phosphatidylcholines immunology, Radioallergosorbent Test, Skin Tests, Asthma immunology, Cooking, Occupational Diseases immunology, Occupational Exposure, Phosphatidylcholines adverse effects, Glycine max
- Abstract
We report two cases of soybean-lecithin-induced asthma in bakers. The patients experienced clinical symptoms in relation to an occupational exposure to this additive. Skin tests were positive with soybean lecithin, RAST showed a sensitization to soybean, and bronchial challenge tests were positive for a dilution of 10(-3) with this allergen. The same tests remained negative among healthy and asthmatic controls. Soybean lecithin, a common additive in bakery, must be added to the list of numerous aeroallergens involved in baker's asthma.
- Published
- 1994
- Full Text
- View/download PDF
39. [Bronchial epidermoid carcinoma with unusual disclosure].
- Author
-
Perdu D, Varini E, Louis B, Lavaud F, Prevost A, Bongrain E, Arav E, and Diebold MD
- Subjects
- Carcinoma, Bronchogenic pathology, Carcinoma, Squamous Cell pathology, Fatal Outcome, Female, Humans, Middle Aged, Pancreatic Neoplasms pathology, Tomography, X-Ray Computed, Carcinoma, Bronchogenic secondary, Carcinoma, Squamous Cell secondary, Lung Neoplasms pathology, Pancreatic Neoplasms secondary
- Abstract
Dissemination has often occurred before the diagnosis of bronchopulmonary cancer. Pancreatic metastases are exceptional and are very rarely the revealing manifestation. The authors report a case of a tumour of the pancreas which led to the discover of an bronchogenic epidermoid carcinoma. The relationship between these two tumours lead to the proposed hypothesis of pancreatic metastasis of a bronchogenic carcinoma. Although this situation is rare, the preoperative work-up for bronchogenic carcinoma should include computed tomography of the pancreas if the abdominal echography does not allow complete visualization of the pancreas in cases with suggestive digestive disorders. If a tumour is observed in the pancreas, scan-guided needle biopsy should be performed to enable the histological examination.
- Published
- 1994
40. [Importance of serum TPA determination in bronchopulmonary cancer. A comparative study of CEA, CA 19.9 and NSE].
- Author
-
Prévost A, Passemard F, Perdu D, Vallerand H, Deschamps F, Lavaud F, and Larbre H
- Subjects
- Adenocarcinoma blood, Adenocarcinoma diagnosis, Bronchial Diseases diagnosis, Bronchial Neoplasms blood, Carcinoid Tumor blood, Carcinoid Tumor diagnosis, Carcinoma, Bronchogenic blood, Carcinoma, Bronchogenic diagnosis, Carcinoma, Non-Small-Cell Lung blood, Carcinoma, Non-Small-Cell Lung diagnosis, Carcinoma, Small Cell blood, Carcinoma, Small Cell diagnosis, Carcinoma, Squamous Cell blood, Carcinoma, Squamous Cell diagnosis, Diagnosis, Differential, Humans, Lung Diseases diagnosis, Lung Neoplasms blood, Tissue Polypeptide Antigen, Antigens, Neoplasm, Biomarkers, Tumor, Bronchial Neoplasms diagnosis, CA-19-9 Antigen blood, Carcinoembryonic Antigen blood, Lung Neoplasms diagnosis, Peptides blood, Phosphopyruvate Hydratase blood
- Abstract
This study concerns 45 patients group one suffering from broncho-pulmonary cancer, the diagnosis was obtained by bronchial biopsies or by transparietal puncture using a scanner: there were 35 non-small cell bronchial carcinomas (CNPC) and 10 small cell bronchial cancers (CPC). The control patients (99 patients) were divided up as follows: 44 pleuro-pulmonary infections (group two) and 55 with respiratory failure of various causes other than infectious episodes (group three). In group one the level for TPA was positive in 30 cases (the threshold value was 90 units per litre), 9 for CA 19.9, 7 for ACE and 9 for NSE. The overall sensitivity was thus better for TPA. There was no correlation between TPA and type of tumour histology nor between the different markers. Their association did not improve the sensitivity. The NSE however, remained the most sensitive test for the diagnosis of CPC with six positive tests out of ten. In the control population, the specificity of TPA (66%) was less than that of ACE (100%) or of CA 19.9 (94%) and the false positives were significantly more numerous in group two: 21 patients had a positive test compared to only 12 in group three. Finally we noticed an increase in the level of TPA contrary to other markers, as a function of the extent of the disease from the carcinoma (CNPC unique). The TPA is thus the most sensitive and it turns out to be better reflector to the extent of the tumour disease than either ACE, CA 19.9 or NSE but this applies uniquely to non-small cell carcinoma.
- Published
- 1994
41. [Bronchial biopsy, curative treatment for cancer in situ?].
- Author
-
Perdu D, Prévost A, Vallerand H, Lavaud F, Baehrel B, and Caulet T
- Subjects
- Aged, Biopsy, Carcinoma in Situ pathology, Carcinoma, Bronchogenic pathology, Humans, Lung Neoplasms pathology, Male, Pneumonectomy, Bronchoscopy, Carcinoma in Situ surgery, Carcinoma, Bronchogenic surgery, Lung Neoplasms surgery
- Abstract
Bronchial carcinoma in situ is an intra-epithelial proliferation of tumour which does not cross the basement membrane and is asymptomatic. The evidence for this cancer often rests on a biopsy carried out on a bronchus which may show simple inflammation or may even be normal. We report a new observation on a bronchial carcinoma in situ which was completely ablated after a bronchial biopsy. However surgery remains the first form of treatment for bronchial cancer. If the patient is inoperable, endobroncho-cryotherapy, radiotherapy or phototherapy may be tried but tumour recurrence remains a possibility.
- Published
- 1993
42. [Detergent enzymes: has the risk of occupational sensitization disappeared?].
- Author
-
Perdu D, Lavaud F, Cossart C, Legrele S, Passemard F, Deltour G, and Dubois de Montreynaud JM
- Subjects
- Adult, Drug Hypersensitivity diagnosis, Humans, Male, Middle Aged, Occupational Diseases diagnosis, Radioallergosorbent Test, Skin Tests, Asthma chemically induced, Detergents adverse effects, Drug Hypersensitivity etiology, Occupational Diseases chemically induced, Peptide Hydrolases adverse effects
- Abstract
Occupational allergy to enzyme detergents had almost disappeared by the use of preventive measures, both individually and in industries. The occurrence of 8 new cases of asthma in a detergent factory has led to a prospective clinical and aetiological enquiry. Although there was no documentation using the specific provocation test or by measuring respiratory function whilst at work, the occupational character of this asthma seemed possible after taking a history. Sensitization to the enzymes used (Savinase, Maxatase and Biozym P 300 S) was shown by skin tests (8 positive to all the enzymes) and the level of specific IgE to Rast (8 times greater than class 3 for Savinase and Maxitase) and for HBDT for Maxatase and Biozym P 300 S (greater than 50% in 8 patients). From another stand point the incomplete application of preventive measures within the factory did not seem to totally explain the origin of this sensitization. In fact, it was the study of the morphology of the enzyme grains, which had been introduced into the factory which helped us to explain the mechanism. In effect it was the capsules of the grain which were fissured and thus allowed allergen contact. The replacement of these grains whose envelope was intact, led to the disappearance of the symptoms and confirmed our hypothesis. There remains a continuing risk from occupational sensitization to asthma and it is suggested that there is continued collaboration between the medical profession and industry.
- Published
- 1992
43. Combination chemotherapy with cisplatin, etoposide and gallium chloride for lung cancer: individual adaptation of doses.
- Author
-
Collery P, Morel M, Desoize B, Millart H, Perdu D, Prevost A, Vallerand H, Pechery C, Choisy H, and Etienne JC
- Subjects
- Adenocarcinoma drug therapy, Adenocarcinoma radiotherapy, Carcinoma, Non-Small-Cell Lung drug therapy, Carcinoma, Non-Small-Cell Lung radiotherapy, Carcinoma, Small Cell drug therapy, Carcinoma, Small Cell radiotherapy, Carcinoma, Squamous Cell drug therapy, Carcinoma, Squamous Cell radiotherapy, Cisplatin administration & dosage, Drug Administration Schedule, Etoposide administration & dosage, Humans, Lung Neoplasms drug therapy, Lung Neoplasms radiotherapy, Middle Aged, Antineoplastic Combined Chemotherapy Protocols therapeutic use, Gallium therapeutic use, Gallium Radioisotopes therapeutic use, Lung Neoplasms therapy
- Abstract
Twelve inoperable lung cancer patients were treated with a combination chemotherapy of cisplatinum (CDDP) and etoposide (VP16), as a continuous infusion for 5 days, every 21 days, and with a daily oral administration of GaCl3. Dosages of CDDP and VP16 were adapted in order to obtain an area under the curve (AUC) of 80,000 micrograms l-1.h for plasma total platinum and of 200 mumol.l-1 h for plasma VP16 during each 120 h infusion. GaCl3 was given at the dosage of 400 mg/24h from the time of diagnosis at least until the evaluation after 3 courses of chemotherapy. An objective response was observed in 5 non small cell (NSCLC) lung cancer patients (group 1) and 3 small cell (SCLC) lung cancer patients (group 2). In the other 4 patients with a NSCLC no partial response was noted (group 3). No significant difference in area under the curve (AUC) was noted between the 3 groups, either for plasma total platinum (group 1 = 89,598 +/- 20,843 micrograms l-1.h; group 2 = 88,081 +/- 15,431 micrograms l-1.h; group 3 = 83,820 +/- 13,455 micrograms l-1.h), or for VP16 (group 1 = 227 +/- 41 mumol.l-1 h; group 2 = 217 +/- 29 mumol.l-1.h and group 3 = 211 +/- 30 mumol.l-1.h). The maximal plasma Ga concentrations were 244 +/- 34 micrograms/l in group 1, 112 +/- 57 micrograms/l in group 3 (p less than 0.005) and 243 +/- 132 micrograms/l in group 2. It was then decided to increase the dose of GaCl3 in the further non-responding patients. In 6 responders, 3 additional courses of this combination chemotherapy could have been given without major toxicity, allowing a much more important decrease in the tumor volume in 4 of them. This schedule of treatment should permit the chemotherapy to continue for longer than 6 courses, in order to improve the survival time.
- Published
- 1991
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.